Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Capital Work in Progress

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Capital Work in Progress ₹493 Cr₹670 Cr₹372 Cr₹313 Cr₹327 Cr

What is the latest Capital Work in Progress ratio of MANKIND PHARMA ?

The latest Capital Work in Progress ratio of MANKIND PHARMA is ₹493 Cr based on Mar2023 Consolidated results.
Year Capital Work in Progress
Mar2023₹493 Cr
Mar2022₹670 Cr
Mar2021₹372 Cr
Mar2020₹313 Cr
Mar2019₹327 Cr

How is Capital Work in Progress of MANKIND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2023 ₹493 Cr
-26.38
Mar2022 ₹670 Cr
80.26
Mar2021 ₹372 Cr
18.63
Mar2020 ₹313 Cr
-4.14
Mar2019 ₹327 Cr -

Compare Capital Work in Progress of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹83,865.6 Cr -6.5% -7.6% 57% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr 2% -0.3% 59.8% Stock Analytics
CIPLA ₹112,990.0 Cr 6% 2.8% 50.4% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 2.6% 7.9% 94.3% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr 3.7% 5.8% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -1.3% -2.8% 31.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.5%

-7.6%

57%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses